2-((tert-Butoxycarbonyl)amino)-4-chloronicotinic acid

Catalog No. :
ACKCBO265
CAS No. :
1021339-32-1
Molecular Formula :
C11H13ClN2O4
Molecular Weight :
272.69

IUPAC Name:2-((tert-butoxycarbonyl)amino)-4-chloronicotinic acid

2-((tert-Butoxycarbonyl)amino)-4-chloronicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$369.00Login to see priceInquiryInquiry
250mg95%$717.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((tert-Butoxycarbonyl)amino)-4-chloronicotinic acid
IUPAC Name2-((tert-butoxycarbonyl)amino)-4-chloronicotinic acid
MDL No.MFCD09965909
Molecular FormulaC11H13ClN2O4
Molecular Weight272.69
SMILESO=C(O)C1=C(NC(OC(C)(C)C)=O)N=CC=C1Cl
InChI KeyPMEJHBACZUJEML-UHFFFAOYSA-N
SynonymMFCD09965909 | Oxytitamium phthalocyanine | AKOS015838205 | WQB33932 | DTXSID20649798 | SCHEMBL22493930 | 2-(tert-Butoxycarbonylamino)-4-chloronicotinic acid, AldrichCPR | CS-0364198 | 2-[(tert-butoxycarbonyl)amino]-4-chloropyridine-3-carboxylic acid | 2-
CAS No.1021339-32-1
PubChem CID26076343

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKCBO265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKCBO265 route product structure diagram
    ACKCBO2651021339-32-1
Inquiry

2. ACKCBO265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLPTU905 route compound structure diagram
    ACLPTU905605661-83-4 In Stock
  4. Then
  5. ACKCBO265 route product structure diagram
    ACKCBO2651021339-32-1
Inquiry

Comments (0)